Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.90
Bid: 17.90
Ask: 18.70
Change: -0.25 (-1.35%)
Spread: 0.80 (4.469%)
Open: 18.10
High: 18.10
Low: 17.90
Prev. Close: 18.55
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 Nov 2009 07:00

3 November 2009 LMS Capital plc Interim Management Statement

LMS Capital plc ("LMS Capital" or "the Company") presents its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement relates to the period from 1 July 2009 to 31 October 2009.

LMS Capital is an international investment company which aims to produce high rates of return though a risk diversified portfolio. This diversification is achieved through geographical spread, primarily the US and UK, and through investment in assets of varying maturities. The major focus is in small to medium sized companies in our preferred sectors of energy services, applied technology, media & consumer, medical & healthcare and real estate.

Despite a strong performance in major stock markets, unemployment in the western economies has continued to rise and the available liquidity has been predominantly a function of governments' monetary intervention. Whilst equity markets have shown short term gains, we believe there has been little evidence of a sustained recovery. The volume of private equity and real estate transactions remains low. For the immediate future we remain cautious.

The unaudited net asset value per share at 30 September 2009 was 87 pence, an increase of 5% since 30 June 2009 and a decrease of 2% from 31 December 2008. The principal factor in this increase was the recovery in the public markets. During October we have however seen a weakening in the share prices of our two largest quoted investments, ProStrakan Group and Weatherford International, and this, coupled with a slight strengthening of the US dollar over the same period, means that we estimate that NAV per share at the end of October had fallen back to its end of June level of 83 pence.

During the three months ended 30 September 2009 funds invested by the Company were 10.5 million in unquoted securities and to meet fund calls. Proceeds from realisations of quoted securities and fund distributions were 6.5 million.

The Company's investment portfolio at 30 September 2009 was as follows:

US UK Total GBP'000 % GBP'000 % GBP'000 % Quoted 39,539 18% 23,730 11% 63,269 29% Unquoted 16,275 7% 38,785 18% 55,060 25% Funds 72,248 33% 29,133 13% 101,381 46% Total 128,062 58% 91,648 42% 219,710 100%

The carrying value of the portfolio at 30 September 2009 is based on the valuation of the Company's investment portfolio as at 30 June 2009 with adjustments for transactions in the three months ended 30 September 2009 including price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds and purchases and sales of quoted securities. In addition, where the Company has invested further amounts in its existing unquoted portfolio, such amounts have been written off as fair value adjustments in the period and investments in new unquoted securities in the period are included at cost. The next full valuation of the portfolio will be as at 31 December 2009.

The ten largest holdings at 30 September 2009 (excluding fund interests where the Company has only a minority position) were as follows:

Name Geography Type Book value % of net assets GBP'000 Weatherford US Quoted 26,415 11% International Oilfield services Prostrakan Group plc UK Quoted 21,650 9% Specialty pharmaceuticals Method Products US Fund portfolio 10,963 8% Consumer products company Rave Reviews Cinemas US Unquoted 6,210 3% Cinema operations Updata Infrastructure UK Unquoted 6,200 3% UK Wide area networks Kizoom Transport UK Unquoted 6,000 3% information systems Wesupply B2B UK Unquoted 5,500 2% connectivity software Penguin Computing US Fund portfolio 5,345 2% Linux server systems company Gulfmark Offshore US Quoted 5,084 2% Offshore services Yes To Consumer US Fund portfolio 3,857 2% products company 97,224 45%

At 30 September 2009 the Company had uncalled commitments to funds of 62.6 million which we expect to be called over the next five years. Cash and other liquid assets (including the value of our quoted portfolio) were 84.7 million. The Company has no debt.

Portfolio subsidiaries

The latest available trading results for our portfolio subsidiaries are to 30 September and these indicate that 2009 continues to produce mixed results. Updata, in which we acquired our interest in July this year, has performed well and its results to September are ahead of budget. Entuity, our network management software business, is also trading ahead of budget with significantly improved profitability. Kizoom and Coppereye have encountered difficult trading conditions in 2009 and their results for the period have been disappointing. Members of our investment team are working closely with the management of these companies to achieve improvements in their operating performance.

This statement is a general description of the financial position and performance of the Company for the period from 1 July 2009 to 31 October 2009. It does not contain any profit forecast or forward looking information. Future performance and share price is likely to be affected by a number of factors, including (but not limited to) general economic and market conditions and specific factors affecting the financial performance or prospects of individual investments within the Company's portfolio.

vendor
Date   Source Headline
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.